Asia Pacific Omics-Based Clinical Trials Market Growth
The Asia Pacific Omics-based clinical trials market is expected to grow at a significant CAGR, owing to immense population diversity in Asia Pacific countries coupled...
AstraZeneca Eyes Acquisition To Develop Cell Therapies
In a recent move, AstraZeneca has agreed to the acquisition of EsoBiotec – the Belgian biotech company for almost $1 billion.
Apparently, the deal happens...
Biopharmaceutical Manufacturing With Continuous Processing
In the recent years that have gone by, the pharmaceutical sector has gone on to see significant progress, thereby generating a novel set of...
CDMO Growth and Biotechnology Outsourcing Trends
Since many contract manufacturing companies (CMOs) are the only ones able to produce the vast quantities of medications and treatments required, outsourcing has grown...
Continuous Bioprocessing Market to Surge by 2028
Currently under development is a major shift towards constant bioprocessing in the biopharmaceutical industry. Unlike the traditional batch processing approach, which is distinguished by...
Advancing Asia-Pacific Healthcare & Biopharma Innovation
In order to improve healthcare and hasten drug research in their home markets, some Asian-Pacific municipal governments have established sensible policies and laws within...
Generative AI in Pharma: Opportunities & Challenges
Regarding the readiness of the life sciences sector to successfully use generative AI in terms of infrastructure, regulatory considerations, and expertise, 67% of pharmaceutical...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...